Grifols | GRFS - 負債





負債 変化する 日付
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Arca Biopharma USD 0 0 2025-03
aTyr Pharma USD 1.81M 29K 2026-03
Bio Path USD 261K 261K 2025-03
Brainstorm Cell Therapeutics USD 1.2M 1.2M 2025-03
Capricor Therapeutics USD 3.38M 0 2025-03
Cara Therapeutics USD 0 0 2025-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Immunic USD 0 0 2024-06
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Sangamo BioSciences USD 0 0 2022-06
TherapeuticsMD USD 93.6M 2.82M 2022-09